News

MediNatura Initiates Nationwide Recall of Key Nasal Sprays

MediNatura Initiates Nationwide Recall of Key Nasal Sprays

MediNatura’s Nationwide Recall Announcement

MediNatura New Mexico, Inc. has launched a significant voluntary recall of its ReBoost Nasal Spray, alongside the ClearLife Allergy Nasal Spray, due to potential microbial contamination. This recall is critical as the company has identified contamination of the product with yeast, mold, and specific microbial strains, notably Achromobacter, which exceeds acceptable levels. The precautionary measure underscores the necessity for consumer safety as investigations into the matter continue.

What You Need to Know About the Recall

Both ReBoost and ClearLife sprays have been recalled across all lots intended for consumer use. The safety checks revealed that these products hold a potential risk, especially for individuals in immune-compromised situations. Consumers are advised to discontinue any use of these products immediately. Thankfully, MediNatura has not received reports relating to adverse health events due to this recall.

Details of the Affected Products

The ReBoost Nasal Spray acts as a homeopathic remedy that alleviates nasal congestion and related sinus issues. It is available in a 20mL bottle, enclosed within an eye-catching white and yellow carton. The relevant NDC number is 62795-4005-9, with UPC# 787647 10186 3. Any ReBoost products with expiration dates ranging from December 2022 to December 2025 are included in this recall.

Similarly, ClearLife Allergy Nasal Spray is meant to tackle minor allergy symptoms. The product also comes in a 20mL bottle located within a white and green carton. The NDC number for ClearLife is 62795-4006-9, and the UPC# is 787647 10188 7. Like ReBoost, all ClearLife products still within their expiration date between December 2022 and December 2025 are recalled.

Identifying the Products

Consumers can distinguish these products by examining the labelling on both bottle and carton packaging. This method of identification plays a crucial role in ensuring product safety.

Immediate Actions for Consumers

All customers are urged to stop using the affected products and seek refunds. If purchased directly from MediNatura New Mexico, Inc., consumers can contact the company to initiate a refund. Retail customers should return the product to the place of purchase for full reimbursement. To ensure clarity of the process, customer inquiries can be addressed through phone contact or by utilizing the company's support team.

Helpful Contact Information

For consumers who purchased ReBoost or ClearLife, reach out to MediNatura New Mexico, Inc. at 800-621-7644 for further assistance. It's advisable to report any health issues that might have sparked from the use of these products to a healthcare provider.

Additionally, adverse reactions can be reported to the FDA's MedWatch Adverse Event Reporting program. Users may file complaints online or through traditional mail. This feedback loop is essential for consumer safety and product quality monitoring.

The Community Follows Up

The initiative for this recall operates with collaboration and knowledge from the U.S. Food and Drug Administration (FDA). Their involvement emphasizes the seriousness of maintaining healthcare standards and safety protocols for all products available to consumers.

Frequently Asked Questions

What prompted the recall of MediNatura’s nasal sprays?

The recall was prompted by findings of microbial contamination in both ReBoost and ClearLife nasal sprays, including levels of Achromobacter beyond safety specifications.

How can customers identify the recalled products?

Customers can identify the recalled ReBoost and ClearLife nasal sprays through their specific NDC and UPC numbers, as well as the appearance of the white and yellow or white and green cartons respectively.

What steps should consumers take if they have the recalled sprays?

Consumers should stop using the products immediately and request a refund. Contact MediNatura directly for instructions or return the product to the place of purchase.

Will customers receive a refund for the recalled products?

Yes, customers who purchased the recalled products can receive a full refund by contacting MediNatura or returning to the retailer where it was purchased.

How can adverse effects from using these products be reported?

Any adverse effects can be reported to the FDA’s MedWatch program either online or via mail. The FDA provides resources for consumers to report issues safely and efficiently.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 148

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 32

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 75

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Rockpool Acquisitions Faces Trading Suspension from FCA

Updated Category News Views 230

Trading Suspension of Rockpool Acquisitions Plc Shares LONDON - Recently, the Financial Conduct Authority (FCA) announced an immediate suspension of Rockpool Acquisitions Plc's ordinary shares from the Official List. The suspension was requested by the company itself and serves to protect the interests of investors and maintain market integrity. Details of the Suspension...

Continue Reading
Discover the Growth of Linde Stock Over the Past Decade

Updated Category News Views 262

Linde Stock Performance: A Decade in Review Linde (NASDAQ: LIN) has exhibited exceptional performance in the stock market over the past ten years, showcasing an impressive annualized return of 13.72%. This growth has outpaced the overall market by 2.12%, demonstrating the strength of Linde's business strategies and market presence. Investment Growth Over Ten Years If an...

Continue Reading
Exploring Saudi Arabia's Economic Growth Trends in Q3

Updated Category News Views 377

Saudi Arabia's Economic Overview in Q3 In a remarkable turn of events, Saudi Arabia's economy has reported a year-over-year growth of 2.8% for the third quarter. This growth, as unveiled by preliminary government statistics, has been largely fueled by robust performance in non-oil sectors, indicating a diversification effort from the nation. This positive trend is a...

Continue Reading
ANTHBOT's Quiet Drive Mirrors Athlete's Steadfastness

Updated Category News Views 4

Unveiling Consistent Performance Just like a goalkeeper defends the goal, ANTHBOT defends your lawn—silently and consistently. Partnering up with German goalkeeper Marc ter Stegen in their latest campaign, ANTHBOT is airing a TV blitz across ARD, ZDF, and digital platforms. This ain't just some ad blitz; it's a thoughtful nudge toward understanding how regular, quiet,...

Continue Reading
WisdomTree Earns 2024 Best Places to Work Honors Again

Updated Category News Views 162

WisdomTree Achieves Recognition in Employee Satisfaction WisdomTree, Inc. (NYSE: WT), known for its pioneering approach in the finance sector, has been celebrating another significant achievement. Recognized as a 2024 Best Places to Work in Money Management, this marks the fifth consecutive year the company has attained this honor. The accolades stem from a robust survey...

Continue Reading